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Vestibular dysfunction: a 
frequent problem for adults 
with mitochondrial disease
IntroductIon
Mitochondrial diseases are a diverse group 
of genetic disorders caused by mutations 
in nuclear-encoded and mitochondrial 
DNA (mtDNA)-encoded genes. Distur-
bance in balance is common in adults 
with mitochondrial disease and usually 
attributed to an underlying peripheral 
neuropathy, skeletal myopathy and/or 
cerebellar disease, with limited treat-
ment options. The vestibular system is 
central to balance control, and vestibular 
dysfunction causes vertigo, dizziness, 
oscillopsia, unsteadiness, and associated 
falls. Reports of vestibular dysfunction 
in mitochondrial disease are confined to 
small patient cohorts with limited and/
or inconsistent use of neuro-otological 
assessments.1–3 Furthermore, despite the 
well-recognised association with hearing 
loss,2 the frequency and underlying patho-
physiological basis of vestibular dysfunc-
tion in mitochondrial disease is currently 
unknown.
We have undertaken a large-scale, 
cross-sectional cohort study investigating 
the prevalence, classification and predic-
tors of vestibular dysfunction in adults 
with mitochondrial disease.
PatIents and methods
All procedures were conducted as part 
of routine clinical care. The study was 
performed under the ethical guidelines 
issued by our institution, with written 
informed consent obtained from all partic-
ipants for genetic studies. We included 
adults (aged 16 years or older) attending 
our specialist clinic between May 2016 
and August 2017 with clinicopathologi-
cally and/or genetically confirmed mito-
chondrial disease and a suspected balance 
disorder. This cohort was subsequently 
evaluated by a specialist neuromuscular 
physiotherapist (SH) to exclude non-ves-
tibular balance disorders. Patients with 
suspected vestibulopathy were subse-
quently referred for neuro-otological 
investigations (online supplementary table 
1). Descriptive analyses were conducted 
on patient demographics, reported symp-
toms, neuro-otological and mitochon-
drial diagnoses, Newcastle Mitochondrial 
Disease Scale for Adults (NMDAS; a 
semiquantitative clinical rating scale for 
mitochondrial disease aimed at providing 
a validated and reproducible measure-
ment of disease progression) total scores, 
hearing observations and mtDNA muta-
tion load. NMDAS vision, hearing and 
balance-related subdomain scores were 
presented as median and IQR for those 
with and without neuro-otological diag-
noses and for patients harbouring the 
m.3243A>G mutation in MT-TL1. The 
predictive value of patient-reported symp-
toms and hearing loss was investigated 
using Pearson χ² analyses and risk ratios 
(±95% CIs). A univariate logistic regres-
sion analysis was performed to investigate 
whether total NMDAS or NMDAS subdo-
main scores could predict neuro-otolog-
ical diagnoses (peripheral or central). A 
Mann-Whitney test compared NMDAS 
scores in individuals with and without a 
neuro-otological diagnosis. Spearman’s 
correlation testing explored relationships 
between m.3243A>G mutant load and 
NMDAS total score. Statistical signifi-
cance was set at p<0.05.
results
One hundred and fourteen patients with 
clinicopathologically and/or genetically 
confirmed mitochondrial disease were 
evaluated during the study period. Of 
these, 35% (40/114) with a suspected 
balance disorder were referred for a physio-
therapy assessment (table 1). This revealed 
that patient-reported symptoms clustered 
into five major domains: (1) dizziness; (2) 
light-headedness; (3) loss of balance; (4) 
unsteadiness and (5) falls. Five patients 
were diagnosed with a pure cerebellar 
syndrome and two with a biomechanical 
cause for falls. The remaining patients 
underwent neuro-otological investigations 
and a vestibular abnormality was detected 
in 91% (30/33), of which 77% (23/30) 
had peripheral vestibulopathy (table 1 and 
online supplementary table 1).
Eighty-two per cent (27/33) of patients 
who received neuro-otological testing had 
sensorineural hearing loss (SNHL), with 
coexistent peripheral vestibulopathy in 
74% (20/27). The hearing loss was bilat-
eral in the majority (18/20). However, 
bilateral peripheral vestibulopathy was 
present in only 55% (11/20).
An increased risk of vestibular dysfunc-
tion was identified in patients reporting 
symptoms of dizziness (risk ratio (RR) 
3.33), light-headedness (RR 4.67) and loss 
of balance (RR 1.56), while hearing loss 
predicted peripheral vestibulopathy (RR 
2.22, online supplementary table 2). Mean 
NMDAS total score for the cohort was 
24.88 (range 1.16–76.56). No significant 
difference was observed in NMDAS scores 
between participants with and without 
a neuro-otological diagnosis (Z=0.27, 
p=0.81) and NMDAS total and subscores 
were not predictive of a neuro-otological 
diagnosis (online supplementary table 3 
and online supplementary table 4).
dIscussIon
We present the first large-scale cohort 
study of vestibular dysfunction in adults 
with mitochondrial disease. The overall 
minimum prevalence of vestibular 
pathology in our symptomatic cohort of 
adults with mitochondrial disease was 
26% (30/114), of which 77% was diag-
nosed as peripheral vestibulopathy. Given 
the known predominance of mtDNA 
encoding gene mutations accounting for 
mitochondrial disease in adults, reflected 
in the genetic spectrum of our cohort, we 
suggest these findings should be primarily 
applied to mtDNA-related disorders.
SNHL and peripheral vestibulopathy 
coexisted in 74% (20/27) of patients. 
A substantial proportion of this group 
harboured the m.3243A>G mutation 
(60%, 12/20), frequently associated with 
hearing impairment.2 Although bilateral 
SNHL was present in 78% (18/23) of 
patients with peripheral vestibulopathy, 
only 50% (9/18) had bilateral peripheral 
vestibulopathy. Furthermore, SNHL was 
present in seven patients without periph-
eral vestibulopathy. Taken together, these 
findings suggest SNHL and peripheral 
vestibulopathy progress at variable rates 
or have divergent pathophysiological 
mechanisms. Two patients with bilateral 
peripheral vestibulopathy had previously 
been diagnosed with unilateral periph-
eral vestibulopathy, suggesting a progres-
sive decline in vestibular function. This is 
the first description of either bilateral or 
progressive vestibulopathy in patients with 
maternally inherited diabetes and deafness 
due to the m.3243A>G mutation. Benign 
paroxysmal positional vertigo (BPPV) was 
an additional neuro-otological finding in 
three patients. BPPV is often overlooked 
in patients with neurological comorbid-
ities4 and is a treatable, often curable, 
balance disorder.
The results of this study have informed 
the development of a framework to 
support the identification, investigation 
and management of balance disorders 
in adults with mitochondrial disease 
attending our specialist clinic (online 
supplementary figure 1). Prospective anal-
ysis will further validate the sensitivity and 
specificity of this algorithm and may have 
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Postscript
neurological disorders associated with 
vestibular dysfunction.
This study confirms that vestibular 
dysfunction is an important manifestation 
of mitochondrial disease in adults. Given 
the clear benefits of vestibular rehabilita-
tion,5 identifying and diagnosing people 
with vestibular dysfunction is important 
to ensure appropriate and effective 
management of these disabling symptoms. 
Consequently, referral for neuro-oto-
logical assessment should be considered 
in all adults with mitochondrial disease 
reporting dizziness, unsteadiness or 
SNHL. Ongoing longitudinal analysis 
of our cohort is currently underway to 
determine the natural history of vestibular 
dysfunction in adults with mitochondrial 
disease.
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